JP5788326B2 - ジヒドロキシアセトンのポリマー組成物およびその使用 - Google Patents

ジヒドロキシアセトンのポリマー組成物およびその使用 Download PDF

Info

Publication number
JP5788326B2
JP5788326B2 JP2011534893A JP2011534893A JP5788326B2 JP 5788326 B2 JP5788326 B2 JP 5788326B2 JP 2011534893 A JP2011534893 A JP 2011534893A JP 2011534893 A JP2011534893 A JP 2011534893A JP 5788326 B2 JP5788326 B2 JP 5788326B2
Authority
JP
Japan
Prior art keywords
pdha
copolymer
peg
composition
daltons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011534893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012508173A (ja
JP2012508173A5 (cg-RX-API-DMAC7.html
Inventor
パットナム, デイビッド
デイビッド パットナム,
ピーター ザウェネー,
ピーター ザウェネー,
ジェイソン スペクター,
ジェイソン スペクター,
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell University
Original Assignee
Cornell University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell University filed Critical Cornell University
Publication of JP2012508173A publication Critical patent/JP2012508173A/ja
Publication of JP2012508173A5 publication Critical patent/JP2012508173A5/ja
Application granted granted Critical
Publication of JP5788326B2 publication Critical patent/JP5788326B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/42—Chemical after-treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
JP2011534893A 2008-11-03 2009-11-03 ジヒドロキシアセトンのポリマー組成物およびその使用 Expired - Fee Related JP5788326B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11073408P 2008-11-03 2008-11-03
US61/110,734 2008-11-03
PCT/US2009/063177 WO2010062783A2 (en) 2008-11-03 2009-11-03 Polymer compositions of dihydroxyacetone and uses thereof

Publications (3)

Publication Number Publication Date
JP2012508173A JP2012508173A (ja) 2012-04-05
JP2012508173A5 JP2012508173A5 (cg-RX-API-DMAC7.html) 2012-12-27
JP5788326B2 true JP5788326B2 (ja) 2015-09-30

Family

ID=42226353

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011534893A Expired - Fee Related JP5788326B2 (ja) 2008-11-03 2009-11-03 ジヒドロキシアセトンのポリマー組成物およびその使用

Country Status (6)

Country Link
US (2) US8916143B2 (cg-RX-API-DMAC7.html)
EP (1) EP2362788B1 (cg-RX-API-DMAC7.html)
JP (1) JP5788326B2 (cg-RX-API-DMAC7.html)
CN (2) CN104774326B (cg-RX-API-DMAC7.html)
BR (1) BRPI0921791B1 (cg-RX-API-DMAC7.html)
WO (1) WO2010062783A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5788326B2 (ja) 2008-11-03 2015-09-30 コーネル ユニバーシティー ジヒドロキシアセトンのポリマー組成物およびその使用
EP3960215B1 (en) 2009-12-15 2024-10-16 Incept, LLC Implants and biodegradable fiducial markers
US10300026B2 (en) 2015-08-24 2019-05-28 Shanxi Yabao Health Products Co., Ltd. Use of dihydroxyacetone in preparation of anti-cancer medicaments
EP3439620B1 (en) * 2016-04-07 2020-12-16 Cornell University Polymeric dha-containing biodegradable compositions and surgical barrier devices made thereof
US10590257B2 (en) 2016-09-26 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Biomimetic, moldable, self-assembled cellulose silica-based trimeric hydrogels and their use as viscosity modifying carriers in industrial applications
US11975123B2 (en) 2018-04-02 2024-05-07 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
US11969526B2 (en) 2017-04-03 2024-04-30 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
US12599706B2 (en) 2017-04-03 2026-04-14 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
CN107141464B (zh) * 2017-05-14 2019-02-19 辽宁大学 一种通过希夫碱载药的两亲性聚碳酸酯聚乙二醇聚合物及其制备方法和应用
EP3860613B1 (en) 2018-10-01 2025-09-10 The Board of Trustees of the Leland Stanford Junior University Injectable hydrogels for controlled release of immunomodulatory compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049795A (en) * 1971-05-14 1977-09-20 Centre D'etudes Experimentales Et Cliniques De Physio Biologie De Pharmacologie Et D'eutonologie Treatment of hemorrhagic shock
EP0884045A1 (en) * 1997-06-06 1998-12-16 Pfizer Products Inc. Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery
US7659420B2 (en) * 2004-05-05 2010-02-09 Cornell Research Foundation, Inc Dihydroxyacetone-based polymers
US7910135B2 (en) * 2006-10-13 2011-03-22 Uluru Inc. Hydrogel wound dressing and biomaterials formed in situ and their uses
WO2008105178A1 (ja) * 2007-02-28 2008-09-04 National University Corporation Hokkaido University リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム
JP5788326B2 (ja) 2008-11-03 2015-09-30 コーネル ユニバーシティー ジヒドロキシアセトンのポリマー組成物およびその使用

Also Published As

Publication number Publication date
US8916143B2 (en) 2014-12-23
EP2362788A2 (en) 2011-09-07
US20110212049A1 (en) 2011-09-01
CN102264399A (zh) 2011-11-30
CN104774326A (zh) 2015-07-15
CN104774326B (zh) 2017-04-12
EP2362788B1 (en) 2016-06-01
EP2362788A4 (en) 2013-04-03
JP2012508173A (ja) 2012-04-05
WO2010062783A3 (en) 2010-07-22
WO2010062783A2 (en) 2010-06-03
CN102264399B (zh) 2015-03-25
BRPI0921791B1 (pt) 2018-10-30
US20150079019A1 (en) 2015-03-19
US9629870B2 (en) 2017-04-25
BRPI0921791A2 (pt) 2015-08-25

Similar Documents

Publication Publication Date Title
US9629870B2 (en) Polymer compositions of dihydroxyacetone and uses thereof
KR101514831B1 (ko) 히알루론산 또는 그의 염 중 하나, 폴리올 및 리도카인의 가열 멸균된 주사용 조성물
RU2697671C1 (ru) Композиция для инъекций гиалуроновой кислоты, содержащей производное гиалуроновой кислоты и ДНК фракцию, и ее применение
Kuo et al. Evaluation of the ability of xanthan gum/gellan gum/hyaluronan hydrogel membranes to prevent the adhesion of postrepaired tendons
Zawaneh et al. Design of an injectable synthetic and biodegradable surgical biomaterial
KR20190012120A (ko) 히알루론산-칼슘 및 폴리라이신을 포함하는 창상 피복재 및 그 제조 방법
KR20010104341A (ko) 메틸리덴 말로네이트를 기재로 한 상처 봉합 물질
JP2013501091A5 (cg-RX-API-DMAC7.html)
CN103083713A (zh) 一种无菌聚合创面覆盖物敷料
US20130252921A1 (en) Adhesion barrier containing hyaluronic acids and l-arginine
Yuan et al. 5-Fluorouracil loaded thermosensitive PLGA–PEG–PLGA hydrogels for the prevention of postoperative tendon adhesion
KR20140100245A (ko) 고분자 조성물 및 이로부터 탄성 창상피복재의 제조방법
CN103159967A (zh) 一种具有自抗炎功能的胶原基海绵伤口敷料的制备方法
Pangesty et al. PVA/gelatin hydrogel loaded with propolis for the treatment of myocardial infarction
Hwang et al. Injectable gelatin-poly (ethylene glycol) adhesive hydrogels with highly hemostatic and wound healing capabilities
CN114514267A (zh) 包含透明质酸和聚乙二醇的生物相容性水凝胶
KR101180286B1 (ko) 히알루론산 에폭사이드 유도체 하이드로겔을 포함하는 유착방지제 및 이의 제조 방법
KR102103180B1 (ko) 히알루론산유도체, 플루란 및 카르복시메틸 셀룰로오스를 포함하는 유착방지용 조성물 및 이의 제조방법
EP3802625B1 (en) Photopolymerized biodegradable copolymer formulations for biomedical applications
KR101074467B1 (ko) 히알루론산 및 l-아르기닌을 함유하는 유착방지제
Huang et al. Development of a new biological dressing: the modified cross-linking of Chitosan derived from cuttlefish (Sepia pharaonis) by-products as an effective agent for promoting cell migration
CN118141972B (zh) 一种可注射止血防粘连水凝胶及其制备方法和应用
CN112206307B (zh) 一种可注射的温敏型水凝胶及其制备方法与应用
Najeb et al. Chitosan-augmented advanced platelet rich fibrin improves the regeneration of superficial digital flexor tendon gap tenorrhaphy in donkeys (Equus Asinus)
WO2024030521A1 (en) Click chemistry hydrogel with minimal swelling as a local delivery vehicle

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121102

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121102

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140514

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140521

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140616

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140623

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140715

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150629

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150722

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150729

R150 Certificate of patent or registration of utility model

Ref document number: 5788326

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees